A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

This study has been completed.

Study NCT00001136 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: January 25, 2000 Last Updated: September 26, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	May 2001 (Final data collection date for primary outcome measure)